DAPAFLOZIN GM 1/500

Dapaflozin GM 1/500 Tablet is a clinically approved triple combination medicine used to manage Type 2 Diabetes Mellitus. It contains:

• Dapagliflozin (10 mg) – An SGLT2 inhibitor that lowers blood sugar by increasing glucose excretion through urine.

• Glimepiride (1 mg) – A sulfonylurea that stimulates insulin release from the pancreas.

• Metformin (500 mg) – A biguanide that reduces hepatic glucose production and improves insulin sensitivity.

This tablet offers a comprehensive solution for blood sugar control, especially for patients needing multi-drug therapy.

Key Benefits:

• Effective reduction of fasting and post-meal glucose levels

• Aids in weight management and may help reduce blood pressure

• Lowers risk of long-term diabetes complications

• Improves overall glycemic control with minimal risk of hypoglycemi